Yazar "Cavusoglu, Y." seçeneğine göre listele
Listeleniyor 1 - 11 / 11
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Association of functional class with social perspectives of heart failure(WILEY-BLACKWELL, 2014) Yucel, H.; Ekmekci, A.; Eren, M.; Bayir, P. Turker; Guray, U.; Cavusoglu, Y.; Firidin, S. N.; Kucukoglu, S.; Ural, D.; Yilmaz, M. B.…Öğe Atrial fibrillation is more prevalent in heart failure patients with hyponatremia: results from treat HF(OXFORD UNIV PRESS, 2016) Cavusoglu, Y.; Eraslan, S.; Kaya, H.…Öğe Comparison of outcome in systolic heart failure patients using ivabradine, digoxin or neither of them: a real life study(WILEY, 2017) Ural, D.; Mutluer, F. O.; Kaya, H.; Beton, O.; Cavusoglu, Y.; Temizhan, A.; Guvenc, T. S.; Gungor, H.; Ege, M. Refiker; Zoghi, M.; Karauzum, K.; Altay, H.; Yilmaz, M. B.…Öğe THE DIRECT COST COMPONENTS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HF-PEF) IN TURKEY: THE RESULTS OF A DELPHI PANEL(ELSEVIER SCIENCE INC, 2016) Aras, D.; Aydogdu, S.; Bozkurt, E.; Cavusoglu, Y.; Eren, M.; Erol, C.; Gulec, S.; Sarioz, F.; Ongen, Z.; Ozdemir, O.; Tokgozoglu, L.; Yeter, E.; Yilmaz, M. B.…Öğe THE DIRECT COST COMPONENTS IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HF-REF) IN TURKEY: THE RESULTS OF A DELPHI PANEL(ELSEVIER SCIENCE INC, 2016) Aras, D.; Aydogdu, S.; Bozkurt, E.; Cavusoglu, Y.; Eren, M.; Erol, E.; Gulec, S.; Sarioz, F.; Ongen, Z.; Ozdemir, O.; Tokgozoglu, L.; Yeter, E.; Yilmaz, M. B.…Öğe The effect of genetic polymorphism on the dose and tlerability to beta-blocker therapy in turkish heart failure population(WILEY-BLACKWELL, 2015) Zoghi, M. Mehdi; Yilmaz, M. B.; Cavusoglu, Y.; Aykut, A.; Onay, H.; Ergene, O.…Öğe Estimated plasma volume as a determinant of heart failure hospitalization: TREAT-HF data(WILEY-BLACKWELL, 2016) Sari, I.; Kaya, H.; Acar, G.; Cavusoglu, Y.; Demir, M.; Gungor, H.; Oguz, D.; Bekar, L.; Sahin, A. A.; Yilmaz, M. B.…Öğe Hyponatremia is highly prevalent and associated with worse clinical outcomes in HF population in Turkiye: results from TRends-HF(Wiley, 2024) Murat, S. Selda; Cavusoglu, Y.; Sahin, A.; Colluoglu, I. T.; Celik, A.; Yilmaz, M. B.[No abstract available]Öğe Influence of influenza vaccination on recurrent hospitalization in patients with heart failure(URBAN & VOGEL, 2017) Kaya, H.; Beton, O.; Acar, G.; Temizhan, A.; Cavusoglu, Y.; Guray, U.; Zoghi, M.; Ural, D.; Ekmekci, A.; Gungor, H.; Sari, I.; Oguz, D.; Yucel, H.; Zorlu, A.; Yilmaz, M. B.The current study aimed to evaluate the influence of regular annual influenza vaccinations on cardiovascular (CV) death and heart failure-related hospitalizations (HFrH) in stable outpatients with heart failure with reduced ejection fraction. The Turkish research team-HF (TREAT-HF) is a network undertaking multicenter, observational cohort studies in HF. This study is a subgroup analysis of TREAT-HF outpatient cohorts who completed a questionnaire on influenza vaccination status and for whom follow-up data were available. A total of 656 patients with available follow-up data for CV death and HFrH including recurrent hospitalization were included in the study. Patients were classified into two groups: those who received regular influenza vaccination (40 %) and those who did not receive vaccination. During a mean follow-up of 15 +/- 6 months, 113 (18 %) patients had CV death and 471 (72 %) patients had at least one HFrH. The CV death rate was similar in both groups of patients (16 vs. 19 %, p = 0.37), whereas, HFrH and recurrent HFrH were significantly less frequently encountered in patients who received regular influenza vaccination than in those who did not receive vaccination (43 vs. 92 % and 16 vs. 66 %, p < 0.001, respectively). In a multivariate Cox proportional hazards model - in addition to a few clinical factors - vaccination status (HR = 0.30, 95 % CI = 0.17-0.51, p < 0.001) and graduation from university (HR = 0.35, 95 % CI = 0.17-0.72, p = 0.004) remained independently associated with the risk of recurrent HFrH. Regular influenza vaccination does not influence CV deaths; however, it decreases HFrH including recurrent episodes of HFrH in outpatients with heart failure with reduced ejection fraction.Öğe Potential clinical application of LCZ696 in patients with chronic heart failure in real life clinical practice: results from TREAT HF Study(OXFORD UNIV PRESS, 2016) Cavusoglu, Y.; Eraslan, S.; Kaya, H.…Öğe The relationship between serum sodium variability and survival in heart failure patients: results from TRends-HF(Wiley, 2024) Murat, S. Selda; Cavusoglu, Y.; Sahin, A.; Colluoglu, I. T.; Celik, A.; Yilmaz, M. B.[No abstract available]
